Consistent with previous studies showing that STAT3 could induce PD-L1 expression in various cancer cells (66–68), we found that cilengitide treatment enhanced the expression of PD-L1 in GBM cells (Figure 7, C–E). This evidence concerns the gene CD274 and glioblastoma.